These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
239 related items for PubMed ID: 39308809
1. Key regulators of vascular calcification in chronic kidney disease: Hyperphosphatemia, BMP2, and RUNX2. Liang X, Li Y, Wang P, Liu H. PeerJ; 2024; 12():e18063. PubMed ID: 39308809 [Abstract] [Full Text] [Related]
3. Signaling pathways involved in vascular smooth muscle cell calcification during hyperphosphatemia. Voelkl J, Lang F, Eckardt KU, Amann K, Kuro-O M, Pasch A, Pieske B, Alesutan I. Cell Mol Life Sci; 2019 Jun; 76(11):2077-2091. PubMed ID: 30887097 [Abstract] [Full Text] [Related]
4. Overexpression of c1q/tumor necrosis factor-related protein-3 promotes phosphate-induced vascular smooth muscle cell calcification both in vivo and in vitro. Zhou Y, Wang JY, Feng H, Wang C, Li L, Wu D, Lei H, Li H, Wu LL. Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1002-10. PubMed ID: 24578384 [Abstract] [Full Text] [Related]
5. Fibronectin/α5 Integrin Contribute to Hypertension-Associated Arterial Ageing and Calcification through Affecting BMP2/MGP Imbalance and Enhancing Vascular Smooth Muscle Cell Phenotypic Transformation. Shi X, Zhang S, Li J, Ke Y, Bai Y. Gerontology; 2024 May; 70(8):858-875. PubMed ID: 38824923 [Abstract] [Full Text] [Related]
6. High-serum phosphate and parathyroid hormone distinctly regulate bone loss and vascular calcification in experimental chronic kidney disease. Carrillo-López N, Panizo S, Alonso-Montes C, Martínez-Arias L, Avello N, Sosa P, Dusso AS, Cannata-Andía JB, Naves-Díaz M. Nephrol Dial Transplant; 2019 Jun 01; 34(6):934-941. PubMed ID: 30189026 [Abstract] [Full Text] [Related]
8. SIRT6 protects vascular smooth muscle cells from osteogenic transdifferentiation via Runx2 in chronic kidney disease. Li W, Feng W, Su X, Luo D, Li Z, Zhou Y, Zhu Y, Zhang M, Chen J, Liu B, Huang H. J Clin Invest; 2022 Jan 04; 132(1):. PubMed ID: 34793336 [Abstract] [Full Text] [Related]
9. Activation of the Nrf2-ARE Signaling Pathway Prevents Hyperphosphatemia-Induced Vascular Calcification by Inducing Autophagy in Renal Vascular Smooth Muscle Cells. Yao L, Wang J, Tian BY, Xu TH, Sheng ZT. J Cell Biochem; 2017 Dec 04; 118(12):4708-4715. PubMed ID: 28513870 [Abstract] [Full Text] [Related]
11. Pathophysiology of Vascular Calcification. Chen NX, Moe SM. Curr Osteoporos Rep; 2015 Dec 04; 13(6):372-80. PubMed ID: 26409849 [Abstract] [Full Text] [Related]
12. Sclerostin is involved in osteogenic transdifferentiation of vascular smooth muscle cells in chronic kidney disease-associated vascular calcification with non-canonical Wnt signaling. Xiao Q, Tang Y, Luo H, Chen S, Chen R, Yan Z, Pu L, Wang L, Li G, Li Y. Ren Fail; 2022 Dec 04; 44(1):1426-1442. PubMed ID: 36017689 [Abstract] [Full Text] [Related]
13. Carbonylation of Runx2 at K176 by 4-Hydroxynonenal Accelerates Vascular Calcification. Zhai X, Cao S, Wang J, Qiao B, Liu X, Hua R, Zhao M, Sun S, Han Y, Wu S, Pang J, Yuan Q, Wang B, Xu F, Wei S, Chen Y. Circulation; 2024 May 28; 149(22):1752-1769. PubMed ID: 38348663 [Abstract] [Full Text] [Related]
14. WNT/β-catenin signaling promotes VSMCs to osteogenic transdifferentiation and calcification through directly modulating Runx2 gene expression. Cai T, Sun D, Duan Y, Wen P, Dai C, Yang J, He W. Exp Cell Res; 2016 Jul 15; 345(2):206-17. PubMed ID: 27321958 [Abstract] [Full Text] [Related]
15. Dihydromyricetin ameliorates vascular calcification in chronic kidney disease by targeting AKT signaling. Feng L, Que D, Li Z, Zhong X, Yan J, Wei J, Zhang X, Yang P, Ou C, Chen M. Clin Sci (Lond); 2021 Nov 12; 135(21):2483-2502. PubMed ID: 34643227 [Abstract] [Full Text] [Related]
16. Impact of C-reactive protein on osteo-/chondrogenic transdifferentiation and calcification of vascular smooth muscle cells. Henze LA, Luong TTD, Boehme B, Masyout J, Schneider MP, Brachs S, Lang F, Pieske B, Pasch A, Eckardt KU, Voelkl J, Alesutan I. Aging (Albany NY); 2019 Aug 03; 11(15):5445-5462. PubMed ID: 31377747 [Abstract] [Full Text] [Related]
17. Estrogen-Related Receptor γ Plays a Key Role in Vascular Calcification Through the Upregulation of BMP2 Expression. Kim JH, Choi YK, Do JY, Choi YK, Ha CM, Lee SJ, Jeon JH, Lee WK, Choi HS, Park KG, Lee IK. Arterioscler Thromb Vasc Biol; 2015 Nov 03; 35(11):2384-90. PubMed ID: 26404484 [Abstract] [Full Text] [Related]
18. Resveratrol ameliorates high-phosphate-induced VSMCs to osteoblast-like cells transdifferentiation and arterial medial calcification in CKD through regulating Wnt/β-catenin signaling. Huang X, Wang Y, Qiu Y, Shi Q, Sun D, Yang J, Dai C, He W. Eur J Pharmacol; 2022 Jun 15; 925():174953. PubMed ID: 35483665 [Abstract] [Full Text] [Related]
19. Sp1 Plays an Important Role in Vascular Calcification Both In Vivo and In Vitro. Zhang X, Li R, Qin X, Wang L, Xiao J, Song Y, Sheng X, Guo M, Ji X. J Am Heart Assoc; 2018 Mar 23; 7(6):. PubMed ID: 29572322 [Abstract] [Full Text] [Related]
20. Ubiquitin-specific protease 47 is associated with vascular calcification in chronic kidney disease by regulating osteogenic transdifferentiation of vascular smooth muscle cells. Xiao Q, Tang Y, Xia J, Luo H, Yu M, Chen S, Wang W, Pu L, Wang L, Li G, Li Y. Ren Fail; 2022 Dec 23; 44(1):752-766. PubMed ID: 35509185 [Abstract] [Full Text] [Related] Page: [Next] [New Search]